EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Replacement‐Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions

Bjorn Fraser Olaisen iD, Vadim N Gladyshev, Bohan Zhang, Anthony Atala iD, Kyle M Loh, Vera Gorbunova, Thomas A Rando, Tony Wyss-Coray, Eric Verdin iD, Alexander Zhavoronkov, Morten Scheibye-Knudsen, Sierra Lore und 1 weitere

Aging Cell · 2026

DOI: 10.1111/acel.70516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Bjorn Fraser Olaisen und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Aging, Longevity, Rejuvenation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological and synthetic replacement‐based ageing interventions hold substantial potential to reverse many forms of age‐related damage simultaneously and extend healthy lifespan beyond what can be achieved with conventional therapeutics. In this Perspective, we discuss recent insights, unmet needs, and emerging trajectories that are catalysing research and clinical development of replacement‐based treatments and synergistic strategies for multi‐targeted damage removal and export at the molecular, organellar, and cellular levels. The first workshop dedicated to replacement as an ageing intervention at the Aging Research & Drug Discovery 2025 conference helped prioritise key challenges, opportunities, and future directions to address the need for preventive replacement and bioengineering technologies capable of inducing systemic and sustained rejuvenation across cells, tissues, and regulatory networks. We propose a roadmap to guide research and innovation integrating replacement and next‐generation damage‐removal therapeutics to modulate the ageing process in the whole body, restore biological function, and extend healthy lifespan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingLongevityRejuvenationAnimalsHumans

Autor:innen und Institutionen

  • University of Cambridge, Cambridge, UK.
  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.
  • Stanford University, Stanford, California, USA.
  • University of Rochester, Rochester, New York, USA.

ORCID-Profile: Bjorn Fraser Olaisen, Anthony Atala, Eric Verdin

Förderung

  • NIA NIH HHS

Zitieren

APA

Olaisen, B. F., Gladyshev, V. N., Zhang, B., Atala, A., Loh, K. M., Gorbunova, V., Rando, T. A., Wyss-Coray, T., Verdin, E., Zhavoronkov, A., Scheibye-Knudsen, M., Lore, S., & Bakula, D. (2026). Replacement‐Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions. Aging Cell. https://doi.org/10.1111/acel.70516

Vancouver

Olaisen BF, Gladyshev VN, Zhang B, Atala A, Loh KM, Gorbunova V, et al. Replacement‐Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions. Aging Cell. 2026. doi:10.1111/acel.70516

BibTeX
@article{Olaisen2026,
  author = {Olaisen, Bjorn Fraser and Gladyshev, Vadim N and Zhang, Bohan and Atala, Anthony and Loh, Kyle M and Gorbunova, Vera and Rando, Thomas A and Wyss-Coray, Tony and Verdin, Eric and Zhavoronkov, Alexander and Scheibye-Knudsen, Morten and Lore, Sierra and Bakula, Daniela},
  title = {Replacement‐Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions},
  journal = {Aging Cell},
  year = {2026},
  doi = {10.1111/acel.70516}
}
Kostenlos starten →